These are the most overbought stocks after a volatile week
Hewlett Packard Enterprise was among this week’s most overbought stocks.
These are the most overbought stocks after a volatile week Read More »
Abel goes his own way with new Berkshire investments, including billions for AI
Warren Buffett tells CNBC’s Becky Quick new Berkshire Hathaway CEO Greg Abel has “launched” with his first major deal.
Abel goes his own way with new Berkshire investments, including billions for AI Read More »
Crypto mutiny on Strategy: Shorts target ‘MSTR’ in bitcoin bloodbath
Flows around Strategy (MSTR) and the company’s variable-rate preferred stock STRC are turning bearish this week.
Crypto mutiny on Strategy: Shorts target ‘MSTR’ in bitcoin bloodbath Read More »
Chip stock breakout vs the rest of tech showing signs of topping out, says Carter Worth
The Philadelphia Stock Exchange Semiconductor Index finally has recouped all its relative losses to the S&P 500 Information Technology Sector.
Chip stock breakout vs the rest of tech showing signs of topping out, says Carter Worth Read More »
Nuveen’s Saira Malik says these are her top three income ideas right now
The Nuveen CIO, who leads a business with $1.4 trillion in assets, explains why she favors these assets within fixed income.
Nuveen’s Saira Malik says these are her top three income ideas right now Read More »
JPMorgan removes sell rating on Tesla after years, says it’s at the ‘forefront of physical AI’
The firm has rated Elon Musk’s electric vehicle company as sell dating back to 2023.
Broadcom’s guidance sent the stock tumbling this week. A buying opportunity has emerged
Jeff Kilburg breaks down how he’s trading Broadcom after this week’s declines.
Broadcom’s guidance sent the stock tumbling this week. A buying opportunity has emerged Read More »
Confirmed screwworm case in Texas sends two biotech stocks higher
Options volume is surging for Zoetis as traders look for potential stock market winners in light of a screwworm case in Texas.
Confirmed screwworm case in Texas sends two biotech stocks higher Read More »
This drugmaker is developing breakthroughs like an ‘EpiPen for heart attacks.’ The market has yet to give it credit
The key to its growth are a non-opioid pain reliever, a potential blockbuster lupus treatment and a drug that has been dubbed an “EpiPen for heart attacks.”
Broadcom sparks a chip stock sell-off. Is this the start of a bigger turn?
Signs pointed to this move being more about about taking profits off extreme highs than moderating AI demand.
Broadcom sparks a chip stock sell-off. Is this the start of a bigger turn? Read More »